Coleman Lewis MD is categorized under Rehabilitation Center, Outpatient Treatment in Chico, CA and active since 2003.
Coleman Lewis MD was established in 2003, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Rehabilitation Center, Outpatient Treatment business, which does work in the B2C market, and is classified as a Rehabilitation Center, Outpatient Treatment, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Lewis Coleman at the company’s single location by writing to 1531 Esplanade, Chico, California CA 95926 or by phoning (530) 332-7330. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Coleman Lewis MD |
Contact Person: | Lewis Coleman |
Address: | 1531 Esplanade, Chico, California 95926 |
Phone Number: | (530) 332-7330 |
Website Address: | enloe.org |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2003 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Rehabilitation Center, Outpatient Treatment |
SIC Code: | 8093 |
NAICS Code: | 6211110 |
Share This Business: |
Coleman Lewis MD was started in 2003 to provide professional Rehabilitation Center, Outpatient Treatment under the SIC code 8093 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Lewis Coleman for inquiries that concern Coleman Lewis MD by calling the company number (530) 332-7330, as your correspondence is most welcome. Additionally, the physical location of the single location of Coleman Lewis MD can be found at the coordinates 39.741942,-121.849043 as well as the street address 1531 Esplanade in Chico, California 95926.
For its online presence, you may visit Coleman Lewis MD’s website at enloe.org and engage with its social media outlets through on Twitter and on Facebook.